SLSP-04

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSLSP-04
Drug Alias NameSLSP-04
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionT lymphocytes stimulantsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSalspera LLC
China Registration ClassN/A

Develop Information

Active CompaniesSalspera LLC
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A